8 months ago
LLY
AnalystsEvan SeigermanEvan Seigerman's Stock Forecasts
AnalystsEvan Seigerman
Analyst Ranking
Bottom 19%
#3956 out of 4861 analysts
Average Return
-0.68%
Win Rate
41%31 out of 75
Risk vs Reward
Poor
Good
Evan Seigerman's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Disc Medicine IncIRON | +165.37% | $22.84 | $60.61 | 2023-03-23 - 2024-03-22 | Buy |
Eli Lilly & CoLLY | +71.55% | $428.44 | $734.97 | 2023-05-04 - 2024-05-03 | Buy |
Structure Therapeutics IncGPCR | +69.29% | $25.56 | $43.27 | 2023-02-28 - 2024-02-28 | Buy |
Eli Lilly & CoLLY | +60.64% | $526.23 | $845.31 | 2023-08-09 - 2024-08-08 | Buy |
Vertex Pharmaceuticals IncVRTX | +42.87% | $293.33 | $419.08 | 2023-02-08 - 2024-02-07 | Buy |
Evan Seigerman Analyst Color
Get additional color on Evan Seigerman's coverage of popular stocks
a year ago
LLY
a year ago
LLY
2 years ago
LLY
2 years ago
LLY
3 years ago
PFE
Evan Seigerman's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Biogen IncBIIB | 14 | Hold | $139.00 | +17.19% | Maintains | 2 months ago |
Gilead Sciences IncGILD | 12 | Buy | $115.00 | +10.01% | Maintains | 2 months ago |
Vertex Pharmaceuticals IncVRTX | 12 | Buy | $520.00 | +6.32% | Maintains | 4 months ago |
Bristol Myers Squibb CoBMY | 11 | Hold | $61.00 | +23.91% | Maintains | 5 months ago |
Incyte CorpINCY | 8 | Sell | $52.00 | -10.67% | Reiterates | 6 months ago |
Neurocrine Biosciences IncNBIX | 10 | Hold | $114.00 | +12.45% | Maintains | 6 months ago |
Eli Lilly & CoLLY | 8 | Buy | $1,101.00 | +31.08% | Maintains | 8 months ago |
Disc Medicine IncIRON | 4 | Buy | $70.00 | +66.01% | Reiterates | 10 months ago |
Structure Therapeutics IncGPCR | 1 | Buy | $40.00 | N/A | Initiates Coverage On | 2 years ago |
Mirati Therapeutics IncMRTX | 4 | Hold | $59.00 | N/A | Downgrades | 2 years ago |
Replimune Group IncREPL | 1 | Buy | $40.00 | N/A | Maintains | 3 years ago |
Regeneron Pharmaceuticals IncREGN | 9 | Buy | $788.00 | N/A | Maintains | 3 years ago |
Nuvation Bio IncNUVB | 2 | Hold | $2.50 | N/A | Downgrades | 3 years ago |
Candel Therapeutics IncCADL | 2 | Buy | $12.00 | N/A | Maintains | 3 years ago |
Pfizer IncPFE | 1 | Buy | $60.00 | N/A | Initiates Coverage On | 3 years ago |
Amgen IncAMGN | 4 | Hold | $228.00 | N/A | Initiates Coverage On | 3 years ago |
Ikena Oncology IncIKNA | 1 | Buy | $30.00 | N/A | Initiates Coverage On | 4 years ago |
Satsuma Pharmaceuticals IncSTSA | 2 | Hold | $6.50 | N/A | Upgrades | 4 years ago |
Galera Therapeutics IncGRTX | 2 | Buy | $15.00 | N/A | Upgrades | 4 years ago |
Aimmune Therapeutics IncAIMT | 3 | Hold | $34.50 | N/A | Maintains | 5 years ago |
Talphera IncTLPH | 5 | Sell | $16.80 | N/A | Maintains | 5 years ago |
Macrogenics IncMGNX | 1 | Buy | $13.00 | N/A | Maintains | 5 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.